These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31427088)

  • 21. The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Parry K; van Rossum PS; Haj Mohammad N; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2017 Jan; 43(1):226-233. PubMed ID: 27424786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
    Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
    Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of mismatch repair deficiency on tumour regression grade after neoadjuvant chemotherapy in localized gastroesophageal adenocarcinoma.
    Heran M; Renaud F; Louvet C; Piessen G; Voron T; Lefèvre M; Dubreuil O; André T; Svrcek M; Cohen R
    Dig Liver Dis; 2023 Feb; 55(2):276-282. PubMed ID: 35780065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
    Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
    Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor regression grade in gastric cancer: Predictors and impact on outcome.
    Blackham AU; Greenleaf E; Yamamoto M; Hollenbeak C; Gusani N; Coppola D; Pimiento JM; Wong J
    J Surg Oncol; 2016 Sep; 114(4):434-9. PubMed ID: 27199217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
    Martin-Romano P; Sola JJ; Diaz-Gonzalez JA; Chopitea A; Iragorri Y; Martínez-Regueira F; Ponz-Sarvise M; Arbea L; Subtil JC; Cano D; Ceniceros L; Legaspi J; Hernandez JL; Rodríguez J
    Br J Cancer; 2016 Sep; 115(6):655-63. PubMed ID: 27537382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma.
    Sada YH; Smaglo BG; Tan JC; Tran Cao HS; Musher BL; Massarweh NN
    J Natl Compr Canc Netw; 2019 Feb; 17(2):161-168. PubMed ID: 30787129
    [No Abstract]   [Full Text] [Related]  

  • 29. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
    Vicente D; Ikoma N; Chiang YJ; Fournier K; Tzeng CD; Song S; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2018 Sep; 25(9):2720-2730. PubMed ID: 29987602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
    Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
    Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
    Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Regression Grade in Gastric Cancer After Preoperative Therapy.
    Ikoma N; Estrella JS; Blum Murphy M; Das P; Minsky BD; Mansfield P; Ajani JA; Badgwell BD
    J Gastrointest Surg; 2021 Jun; 25(6):1380-1387. PubMed ID: 32542556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy.
    Roy P; Serra S; Kennedy E; Chetty R
    J Surg Oncol; 2012 Feb; 105(2):130-4. PubMed ID: 21842520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study.
    Wang Y; Xu H; Hu C; Yu P; Bao Z; Zhang Y; Zhang R; Zhang S; Li B; Aerts JM; Xu Z; Cheng X
    J Gastrointest Oncol; 2022 Jun; 13(3):1046-1057. PubMed ID: 35837180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
    J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [GRP78 expression in gastric cancer and its clinical significance].
    Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.